Recombination at stalled replication forks is regulated at an early stage by sumoylation. In this issue of Cell, Branzei et al. (2006) show that the Ubc9/SUMO modification pathway controls the accumulation of cruciform structures at stalled forks.
tions in BRCA1 or BRCA2 result in an increased susceptibility to breast and ovarian cancer. Yet it is still not clear how BRCA1 and BRCA2 mediate their tumor-suppressor activities. Mouse or human tumor cells deficient in either BRCA1 or BRCA2 exhibit aberrations in chromosome structure, including translocations, deletions, and fusions of multiple chromosomes, suggesting that these proteins help to maintain chromosomal integrity (Venkitaraman, 2002) . BRCA1 is considered to be a caretaker of genome stability, as it is involved in homologous recombination during DNA doublestrand-break repair (Venkitaraman, 2002) . BRCA1 is also part of the signaling cascade that activates the cell-cycle checkpoint when DNA damage occurs (Yarden et al., 2002) . Defects in DNA repair and DNA damage-response checkpoints could readily compromise chromosomal stability in cells with defective BRCA1. However, it is largely supposition that these functions account for the main tumor-suppressor activity of BRCA1.
BRCA1 exists as a heterodimer with BARD1, a protein to which it is structurally related. Both proteins contain a RING domain (present in E3 ubiquitin ligases) and BRCT motifs that act as specific phosphopeptide-binding domains. BRCA1 interacts with a variety of other proteins that might modulate its biological activity, including BRCA2. Additional functions for BRCA1 are suggested by its localization to centrosomes during mitosis (Hsu and White, 1998) and by the finding that BRCA1-defective cells may have abnormal numbers of centrosomes (Sankaran and Parvin, 2006) . BRCA1 and BARD1 levels increase in mitotic cells, and the proteins are hyperphosphorylated (Choudhury et al., 2005) , suggesting that BRCA1/ BARD1 may participate in mitosis, thus contributing to the preservation of chromosomal integrity. However, it is always difficult to assign specific mitotic roles to proteins that are also important during interphase. In this issue of Cell, Joukov et al. (2006) solve this dilemma by using Xenopus egg extracts to dissect the mitotic function of the BRCA1/BARD1 heterodimer.
Spindle assembly can be recapitulated in concentrated extracts prepared from the eggs of Xenopus laevis, which are arrested in metaphase of meiosis II (a mitosis-like state). These metaphase extracts are an excellent model system for dissecting the mitotic role of a protein from its other effects on cell-cycle progression, transcription, or DNA replication. Using such extracts, the role of the GTPase Ran in microtubule stabilization and spindle assembly during mitosis has been separated from its function during interphase, where it directs transport of macromolecules between the cytoplasm and the nucleus. The GTP-bound form of Ran (Ran-GTP) is generated around chromosomes by the guanine nucleotide exchange factor RCC1 (Figure 1 ). Ran-GTP releases spindle-assembly factors from inhibitory complexes with importins, thereby promoting microtubule nucleation, stabilization, and the assembly of the spindle
A Mitotic Role for BRCA1/BARD1 in Tumor Suppression?
The tumor-suppressor protein BRCA1 is thought to act by preserving genomic integrity. In this issue of Cell, Joukov et al. (2006) demonstrate that the BRCA1/BARD1 heterodimer participates in mitotic spindle assembly, a process conducted by the GTPase Ran. Loss of this mitotic function might contribute to tumorigenesis. (Clarke and Zhang, 2001) .
In extracts that cycle between interphase and mitosis, Joukov et al. (2006) observed that BRCA1 and BARD1 associate with chromatin during interphase and are released from chromatin during mitosis. Using antibodies generated against BRCA1 or BARD1, the authors depleted these proteins from egg extracts. In these cycling extracts, BRCA1/ BRAD1 depletion did not alter the timing of cell-cycle progression but caused the formation of nuclei that were heterogeneous in size. It is not clear whether this reflected a failure to assemble nuclei of normal size or a missegregation of chromosomes leading to an irregular complement of chromosomes in each nucleus. Joukov et al. (2006) interpret their finding as evidence for a requirement of BRCA1/BARD1 for passage through mitosis because a similar effect on nuclear assembly is not seen in interphase-arrested extracts depleted of BRCA1/BARD1.
In Xenopus egg extracts arrested in metaphase, depletion of BRCA1/ BARD1 disrupted chromosome congression to the middle of spindles formed in vitro. There was a higher density of spindle microtubules, but they were unfocused at the poles. Depletion of BRCA1 and BARD1 from human HeLa cells using small interfering RNAs (siRNAs) caused defects in spindle structure that were broadly consistent with the defects seen in Xenopus egg extracts. Strikingly, these defects are reminiscent of those induced by disrupting RCC1 localization or the expression of Ran mutants defective in their GTP/GDP cycle (Moore et al., 2002) . Despite such mitotic defects, BRCA1/BARD1-deficient cells do exit mitosis. However, some lagging chromosomes became enclosed in separate nuclear envelopes, leading to the formation of micronuclei.
To test whether BRCA1/BARD1 might have a function downstream of Ran in spindle assembly, Joukov et al. (2006) examined the effects of BRCA1/BARD1 depletion on the formation of microtubule asters that form upon addition of exogenous Ran-GTP. The asters that assembled in BRCA1/BARD1-depleted extracts were larger, with poorly focused microtubules. To understand how BRCA1/BARD1 might function in this assay, Joukov et al. (2006) examined the localization of four potential effectors-NuMA, γ-tubulin, TPX2, and XRHAMM-in BRCA1/BARD1-depleted Xenopus extracts. Although the accumulation of NuMA at aster poles seemed normal, γ-tubulin and XRHAMM localization was more diffuse, and TPX2 became localized along the length of microtubules instead of at the poles. Importantly, Ran-dependent aster formation and the polar localization of TPX2 were fully restored by addition of recombinant BRCA1/ BARD1, but not by a BRCA1/BARD1 heterodimer defective in its ubiquitin ligase activity. Similarly, centrosome-dependent aster formation and spindle assembly were also disorganized by depletion of BRCA1/ BARD1, and TPX2 failed to concentrate at each pole. Comparable effects on TPX2 localization were found when BRCA1 and BARD1 were depleted from HeLa cells by siRNA. Immunoprecipitation revealed an interaction between BRCA1/BARD1 and XRHAMM, NuMA, and TPX2 that was not mediated by microtubules. Additional experiments demonstrated that XRHAMM is hyperactive in BRCA1/BARD1-depleted extracts and that this hyperactivity causes the mislocalization of TPX2 and aberrant spindle assembly. Joukov et al. (2006) suggest that ubiquitination of XRHAMM by BRCA1/ BARD1 may contribute to the proper localization of TPX2 to the poles.
The study by Joukov et al. (2006) provides clear evidence that BRCA1/ BARD1 has a distinct role in mitosis. These results are in broad agreement with previous work by Sankaran et al. (2005) , who found that siRNA-mediated depletion of BRCA1 increased microtubule nucleation at centrosomes, whereas excess BRCA1 inhibited aster formation in Xenopus egg extracts. Joukov et al. (2006) propose that BRCA1/BARD1 acts through established spindleassembly factors to control the proper organization of microtubules (Figure 1 ). Given that TPX2 also interacts with the oncogenic kinase Aurora A, which phosphorylates BRCA1, as well as HURP (hepatocarcinoma-upregulated protein), a network of interactions orchestrated by Ran-GTP seems to be emerging that controls mitotic spindle assembly and is disrupted in cancer (Sanderson and Clarke, 2006) .
The new work poses a number of questions regarding the mechanism and significance of these findings for understanding the tumor-suppressor function of BRCA1. First, how does the BRCA1/BARD1 dimer control XRHAMM and TPX2, and what is the role of its ubiquitin ligase activity? Perhaps BRCA1/BARD1 is involved in the precise spatial regulation of the activity of spindle-assembly factors through local inhibition of XRHAMM. BRCA1 has been found concentrated at centrosomes (Hsu and White, 1998) , although this localization has not been confirmed by Joukov et al. (2006) . Second, what is the relationship between BRCA1/BARD1 and Ran? Although BRCA1/BARD1 seems to act downstream of Ran, it is not clear whether it works in parallel with the activation of spindle-assembly factors by Ran-GTP or whether BRCA1/BARD1 itself is regulated by Ran. Both BRCA1 and BARD1 have been found to move between the nucleus and cytoplasm during interphase, and they contain nuclear import and export motifs that could also interact with Ran effectors during mitosis. Third, how much do the effects on the localization of XRHAMM, TPX2, and perhaps NuMA account for the role of BRCA1/BARD1 in mitotic spindle assembly? Other studies have indicated that BRCA1 may also catalyze the ubiquitination of centrosomal components including γ-tubulin and therefore might have more direct effects on centrosome function (Sankaran and Parvin, 2006; Sankaran et al., 2005) . More generally, to what extent does the function of BRCA1/BARD1 in mitotic spindle assembly account for chromosomal instability when its function is compromised, and how does this relate to the development of tissuespecific tumors? Given that breast and ovarian tumors are two of the most common forms of cancer and account for a substantial number of cancer-related deaths in women, answers to these questions are of vital interest to more than just cell biologists.
